Carbon Oxygen Demand Standards
Apexbio Technology LLC Amoxicillin Sodium 34642-77-8 10g
Amoxicillin Sodium (CAS 34642-77-8) is a small-molecule inhibitor targeting bacterial cell wall biosynthesis It is designed to disrupt peptidoglycan formation thereby compromising bacterial cell wall integrity Amoxicillin Sodium exerts its biological activity primarily through inhibition of peptidoglycan biosynthesis leading to bacterial lysis and cell death In in vitro studies Amoxicillin Sodium demonstrates broad-spectrum antibacterial inhibitory activity with IC50 values ranging from 0 1 g/mL to 10 g/mL depending on bacterial strain variability and experimental conditions Based on these pharmacological properties Amoxicillin Sodium holds research potential in bacterial physiology characterization antibiotic resistance evaluations and in vitro infection modeling studies
Apexbio Technology LLC L-Acetylcarnitine (hydrochloride) 5080-50-2 10g
L-Acetylcarnitine (hydrochloride) (CAS 5080-50-2) an acetylated derivative of L-carnitine facilitates the mitochondrial uptake of acetyl-CoA supporting fatty acid oxidation and energy metabolism It enhances acetylcholine synthesis and contributes to membrane phospholipid and protein production In vitro L-acetylcarnitine reduces SKOV-3 ovarian cancer cell proliferation at higher concentrations without affecting CA-125 or nerve growth factor receptor expression In vivo studies demonstrate its rapid and sustained antidepressant-like activity in rodent models linked to epigenetic upregulation of mGlu2 (Grm2) receptors L-acetylcarnitine is utilized in research focusing on metabolism neurobiology and psychiatric disorders
Apexbio Technology LLC PTP Inhibitor I 2491-38-5 10g
PTP Inhibitor I (CAS 2491-38-5) is a small molecule inhibitor targeting protein tyrosine phosphatases (PTPs) specifically SHP-1 and PTP1B with inhibition constants (KI) of 43 M and 42 M respectively As an -bromoacetophenone derivative it acts as a neutral phosphotyrosine mimetic covalently modifying the active site cysteine of PTPs Structure-activity studies indicate that modifications to the phenyl ring moderately affect potency while para-substituted peptidyl groups can enhance both potency and selectivity PTP Inhibitor I is utilized in vitro for mechanistic studies of PTP function related to diabetes neurodegenerative disorders immune regulation and pathogen virulence Animal and clinical data are not available
Apexbio Technology LLC Bisphenol B 77-40-7 10g
Bisphenol B (CAS 77-40-7) is a synthetic bisphenol compound structurally analogous to bisphenol A It functions as an endocrine-disrupting chemical by binding to and activating estrogen receptors thereby mimicking the action of endogenous estrogens and potentially altering hormonal signaling pathways Owing to these properties Bisphenol B is widely utilized in toxicological and biomedical research to investigate endocrine disruption reproductive toxicity and possible health risks associated with environmental exposure to bisphenol analogues Its study supports risk assessment and informs regulatory evaluations of bisphenol-related substances
Apexbio Technology LLC Prilocaine hydrochloride 1786-81-8 10g
Prilocaine hydrochloride (CAS 1786-81-8) is a local anesthetic belonging to the amino amide class It functions by reversibly inhibiting voltage-gated sodium channels on neuronal cell membranes thereby blocking the initiation and propagation of nerve impulses This property makes it suitable for investigating neuronal excitability pain signaling and ion channel pharmacology in various preclinical models Prilocaine hydrochloride is commonly employed in studies requiring local anesthesia and serves as a reference compound for benchmarking novel anesthetic agents in research settings
Apexbio Technology LLC Docosanol (Abreua) 661-19-8 10g
Docosanol Abreua (CAS 661-19-8) is a small-molecule inhibitor targeting herpes simplex virus (HSV) It is designed to inhibit viral entry processes thereby preventing HSV replication at the initial stage of infection Docosanol Abreua exerts its biological activity primarily through the inhibition of viral envelope fusion with host cell membranes In cell-based studies Docosanol Abreua demonstrates antiviral inhibition with an IC50 value typically in the range of approximately 2 5-5 M Based on these pharmacological properties Docosanol Abreua holds research potential in antiviral mechanism studies investigation of viral entry pathways and host pathogen interaction assays
TARGETMOL CHEMICALS INC DESCHLOROCLOZAPINE 25MG
Also available in 5 mg 10 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Deschloroclozapine a metabolite of Clozapine is a highly potent muscarinic DREADDs agonist. Deschloroclozapine binds to DREADD receptor subtypes hM3Dq and hM4Di with Ki of 6.3 and 4.2 nM respectively. purity: 99%
Hach Company COD Standard Solution, 1000 mg/L as COD (NIST), 200 mL
For accuracy checks in Chemical Oxygen Demand determinations. 200 mL bottle
